People suffering from angina or heart failure may not do day to day work easily Such as walking, Going in market, climbing steps.For all these heart patients there is a non-invasive treatment called EECP therapy available that clinical experience has shown to be safe and to have benefit for the treatment of angina and heart failure. Around 80% of patients who completed this treatment experienced significant symptom relief that may last longer than bypass surgery or stent.
EECP works by pumping blood from the legs upward to the heart while the heart is at rest. The mechanism improves circulation throughout the body, promotes angiogenesis, and has long-term, positive effects.
EECP Therapy is a safe, simple non-surgical option for patients suffering from ischemic heart diseases such as angina and heart failure. EECP improves the flow of healthy, oxygenated blood to the heart by opening or forming small blood vessels called collaterals which create natural bypasses around blocked arteries.
EECP is the only non-invasive treatment for coronary artery disease, angina and congestive heart failure. The procedure reduces or eliminates angina, increases energy and helps patients return to a more active lifestyle. Patients who learn about EECP can get treated for a variety of diseases and condition: Chronic stable angina (lack of blood to the heart that causes severe chest pains), Coronary Artery Disease, High Blood Pressure Congestive heart failure, Heart Attack, Cardiovascular Disease At Global Cardio Centers we have helped hundreds of thousands of patients since 20002 improve their cardiovascular function. Our physicians see improvement as a result of EECP for people suffering from stroke, diabetes, high blood pressure, angina/chest pain, heart failure, heart attack, and diseases like obesity, kidney failure, eye disease, and more.
People may experience the following direct benefit after 35 hours or more of EECP treatment:
The squeezing mechanism of EECP improves the hemodynamics of blood flow and shear stress to help elevate levels of nitric oxide and vascular endothelial growth factor from the endothelium (lining of the arterial walls). Nitric oxide is a vasodilator that opens and relaxes arteries to help improve circulation. During EECP nitric oxide contributes to less arterial stiffness and improved function of endothelial cells.
Vascular endothelial growth factor (VEGF) is a hormone elevated during EECP that helps stimulate angiogenesis, the growth of new collaterals for blood flow around blockages, like a NaturalBypass®. EECP helps grow new arteries naturally and improves arterial function.
Regenerative therapy is the process of replacing or regenerating human cells, tissues or organs to restore or establish normal function. During EECP therapy, due to the blood flow, stem cells (progenitor and hematopoietic cells) found in bone marrow are excreted into the circulatory system resulting in repair of organ dysfunction. For example, patients with diabetes often see improved function of the pancreas when EECP therapy REGENERATES PANCREATIC TISSUE TO PRODUCE INSULIN.